Back to Impax Asset Management Group plc Impax Asset Management Group plc

LGNDLGND

Showing 8 of 30 quarters

Position history for Impax Asset Management Group plcImpax Asset Management Group plc's holdings in Ligand Pharmaceuticals Incorporated

Yes. Impax Asset Management Group holds 130,000 shares of LGND (Ligand Pharmaceuticals), worth $41.1M, as of its Q2 2026 13F filing. It reduced the position by 22,444 shares (-14.7%) from Q1 2026. Impax Asset Management Group has held LGND in every 13F on record since Q1 2019, 30 quarterly filings. LGND is 0.3% of Impax Asset Management Group's reported 13F portfolio.

Current Value

$41.1M

Current Shares

130,000

Total Value Change

+$13M

Total Shares Change

-150,208

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
130,000
-14.7%
$41.1M0.3%$316.09
0
2026-Q1
Decreased
152,444
-7.7%
$30.4M0.2%$199.65
0
2025-Q4
Decreased
165,208
-17.5%
$31.2M0.2%$189.07
0
2025-Q3
Decreased
200,208
-23.1%
$35.5M0.2%$177.14
0
2025-Q2
Decreased
260,208
-7.1%
$29.6M0.2%$113.68
0
2025-Q1
Unchanged
280,208
0.0%
$29.5M0.2%$105.14
0
2024-Q4
Unchanged
280,208
0.0%
$30M0.1%$107.15
0
2024-Q3
Unchanged
280,208
0.0%
$28M0.1%$100.09
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used